Karyopharm Therapeutics Inc. (KPTI) Net margin 2016–2025
Karyopharm Therapeutics Inc. (KPTI) net profit margin by fiscal year — reported net income divided by reported revenue.
-134.2%FY2025 · since FY2016: -71153.9% → -134.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -134.2% | -81.6 pp |
| FY2024 | -52.6% | +45.4 pp |
| FY2023 | -98.0% | +7.2 pp |
| FY2022 | -105.2% | -46.1 pp |
| FY2021 | -59.1% | +122.5 pp |
| FY2020 | -181.6% | +306.5 pp |
| FY2019 | -488.1% | +100.0 pp |
| FY2018 | -588.1% | +7448.3 pp |
| FY2017 | -8036.4% | +63117.5 pp |
| FY2016 | -71153.9% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice